ATE437678T1 - Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand) - Google Patents

Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)

Info

Publication number
ATE437678T1
ATE437678T1 AT02735595T AT02735595T ATE437678T1 AT E437678 T1 ATE437678 T1 AT E437678T1 AT 02735595 T AT02735595 T AT 02735595T AT 02735595 T AT02735595 T AT 02735595T AT E437678 T1 ATE437678 T1 AT E437678T1
Authority
AT
Austria
Prior art keywords
sulfamat
oestrone
trail
tnf
compositions
Prior art date
Application number
AT02735595T
Other languages
English (en)
Inventor
Graham Keith Packham
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of ATE437678T1 publication Critical patent/ATE437678T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT02735595T 2001-06-07 2002-06-06 Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand) ATE437678T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113920.3A GB0113920D0 (en) 2001-06-07 2001-06-07 Composition
PCT/GB2002/002541 WO2002098511A1 (en) 2001-06-07 2002-06-06 Compositions comprising oestrone-3-0-sulphamate and trail (tnf-related apoptosis inducing ligand)

Publications (1)

Publication Number Publication Date
ATE437678T1 true ATE437678T1 (de) 2009-08-15

Family

ID=9916140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735595T ATE437678T1 (de) 2001-06-07 2002-06-06 Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)

Country Status (8)

Country Link
US (1) US7211246B2 (de)
EP (1) EP1399221B1 (de)
JP (1) JP4376055B2 (de)
AT (1) ATE437678T1 (de)
DE (1) DE60233136D1 (de)
ES (1) ES2330088T3 (de)
GB (1) GB0113920D0 (de)
WO (1) WO2002098511A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0702446D0 (en) * 2007-02-08 2007-03-21 Sterix Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
ES2253753T3 (es) * 1995-06-29 2006-06-01 Immunex Corporation Citocina que induce apoptosis.
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
AU765386B2 (en) * 1998-06-10 2003-09-18 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-(o)-sulphamate for inhibition of estrone sulphatase
NZ515061A (en) * 1999-04-30 2004-04-30 Sterix Ltd Use of a cyclic compound in cell cycling
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
EA011123B1 (ru) 2003-03-24 2008-12-30 Стерикс Лимитед Производные эстрогена в качестве ингибиторов стероидной сульфатазы

Also Published As

Publication number Publication date
US20040166090A1 (en) 2004-08-26
ES2330088T3 (es) 2009-12-04
WO2002098511A1 (en) 2002-12-12
EP1399221B1 (de) 2009-07-29
GB0113920D0 (en) 2001-08-01
DE60233136D1 (de) 2009-09-10
JP2004537523A (ja) 2004-12-16
EP1399221A1 (de) 2004-03-24
US7211246B2 (en) 2007-05-01
JP4376055B2 (ja) 2009-12-02

Similar Documents

Publication Publication Date Title
BR9916896A (pt) Diaril aminas substituìdas com 1-heterociclo
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
EP1476180A4 (de) Interleukin-2 mutanten mit verringerter toxizität
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
NO20011190D0 (no) Keramiske karbonsammensetninger
TR199901877A3 (tr) Zararli eklem bacaklilarin imhasi için terkip.
DE60206684D1 (de) Zusammensetzungen mit der Eigenschaft der Dilatanz
DE69734397D1 (de) Tumor-nekrose-faktor ähnliches ligand
ES2193539T3 (es) Benzonaftiridinas.
AU2002303694A1 (en) Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
BG105539A (bg) Елетриптан хидробромид монохидрат
SE9903290D0 (sv) Novel compounds
SI1377574T1 (de)
ATE437678T1 (de) Zusammensetzungen mit oestrone-3-o-sulfamat und trail (tnf-related apoptosis inducing ligand)
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
SE0302361D0 (sv) Inhibering av upptagning av monoamin
DK1390364T3 (da) Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression
MXPA03001440A (es) Compuestos de trioxepano novedosos.
DK1144348T3 (da) LTA4-hydrolaseinhibitorer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties